Followers | 186 |
Posts | 19792 |
Boards Moderated | 4 |
Alias Born | 11/29/2010 |

Thursday, May 08, 2025 12:18:53 AM
CEO Park claims his new venture will
"facilitate a major trading operation, including the sale of copper and gold with a total value of $2.8 billion...financing will cover other JP3E contracts. This includes $35,000,000 specifically for gold and copper transactions.."
..because neither JP3E nor SPOOZ nor his newly formed Korean company apparently has any money to do anything of consequence!!! Even so, he claims he shipped "10,000 MT" (metric tons) of "Copper cathode being shipped as of March 17, 2025." That means this deal should appear in his Q1 report which is due in just over a week!!! But consider this--
Sources report "the cost of copper cathode per metric ton fluctuates, "generally ranges between $8,500 and $9,500." IF TRUE then JKPs claim his first "trial shipment of 10,000 MT on 3/17/25" has a value of $85 - $95 MILLION... with twice that amount each month thereafter for a year!!!
AS PROOF HE POSTED THIS PHOTO IN HIS PR----
What he didn't count on was that I would have his photo examined by Google's "AI IMAGE DETECTOR" which determines whether an image is legit or fabricated. Google reported the following
Analysis successfully completed!
Results
Likelyhood of this image being generated by AI: >>> 97% <<<
(Click this image: https://ml.globenewswire.com/Resource/Download/148fff32-05a9-43c4-89f8-97584de727a8?size=3
Right click > Save Image > Go to Google's https://detect-ai-images.web.app/
PR and image source: https://www.globenewswire.com/news-release/2025/03/20/3046353/0/en/JP3E-Holdings-Inc-establishes-Datang-International-Trading-Co-Ltd-as-Joint-Venture-in-South-Korea-with-China-Datang-Holdings-Group-Corp-Ltd-Acquiring-JP3E-Preferred-Shares-Providin.html

Do not buy, sell or make any investment decision based information or opinion I post. I conduct my own DD. If you don't like it feel free to prove me wrong.
Glidelogic Corp. Announces Release of First AI-Generated Novel "The Thirteenth Proposal" • GDLG • Jul 11, 2025 12:20 PM
Fifty1 AI Labs' REVIVE Clinical Trial Redefines Long COVID Treatment, Pioneering AI-Driven Therapies and Propelling Fifty 1 Labs, Inc. Toward $50M Valuation and Global Biotech Leadership • FITY • Jul 10, 2025 8:30 AM
Aspire Biopharma Holdings, Inc., Announces Positive Consumer Feedback from Company Sampling of BUZZ BOMB™, its New Sublingual Pre-Workout Supplement • ASBP • Jul 9, 2025 9:15 AM
Breaking Through: Systemic Genetic Medicines for Hard-to-Treat Cancers • IBRX • Jul 9, 2025 9:00 AM
Fifty 1 Labs, Inc. Announces Bold Expansion Plan Powered by Nobel Prize Laureate Management Team, Cutting-Edge AI Healthcare Innovation and $350K Leadership Investment • FITY • Jul 8, 2025 8:30 AM
Avant Technologies and Partner, Ainnova, Launch Transformative Preventative Care Model for Chronic Patients Across Latin America • AVAI • Jul 8, 2025 8:00 AM